Back to results
US 2001/0025055 A1Published application
New guanidine derivatives, processes for preparing them and their use as pharmaceutical compositions
OwnerEberhard Amtmann, Norbert Frank +2inventors
InventorsEberhard Amtmann, Norbert Frank, Gerhard Sauer, Gerhard Schilling
Life of this patent
Estimating the term…
Abstract
The invention concerns new guanidine derivatives of formula (I), methods of preparing them and their use in drugs containing such compounds. 1
Claims17
Compounds of general formula I:
- 5
- wherein
- X denotes R1, —NHR1, —NH—NH—CHR1R2, —NH—N═CR1R2, 6
- R1 and R2 independently of each other denote hydrogen, a straight-chained or branched C3-20-alkyl, C3-20-cycloalkyl group, an adamantyl, norbornyl, tricyclodecyl, benzyl, furyl, pyridyl, indolyl, quinolyl, anthracenyl, phenanthryl, perinaphthyl or quinuclidinyl group, whilst the above-mentioned straight-chained or branched C3-20-alkyl group may be substituted by a hydroxy, C1-4-alkoxy group, a halogen atom or an amino group and the above-mentioned C3-20-cycloalkyl group may be substituted by a hydroxy, C1-4-alkoxy, C1-4-alkyl group or by a halogen atom or an amino group, and wherein, if X denotes —NH—N═CR1R2, only one of the substituents R1 and R2 can represent hydrogen,
- optionally in the form of the individual optical isomers, mixtures of the individual isomers or racemates, tautomers such as geometrical isomers e.g. cis/trans isomers, as well as in the form of the free bases or corresponding acid addition salts with pharmacologically acceptable acids.
2 more elements
Dependencies are inferred from the claim text.